產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-DRAK2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-DRAK2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-DRAK2
Cat. Number:
Anti-DRAK2抗體KL-10467R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. Two novel Anti-DRAK2抗體serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases). DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.
Also known as:
DAP kinase related Anti-DRAK2抗體apoptosis inducing protein; DAP kinase related apoptosis inducing protein kinase 2; Death associated protein kinase related 2; DRAK 2; Serine/threonine kinase 17b (apoptosis inducing); Serine/threonine kinase 17b; Serine/threonine protein kinase 17B; STK17B; ST17B_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DRAK2.
●
Predicted Molecular Anti-DRAK2抗體Weight: 42kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-DRAK2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-DRAK2抗體
Optimal working dilutions must be determined by the end user.
kl675Mu02 凝血因子Ⅴ(F5)多克隆抗體 Polyclonal Antibody to Coagulation Factor V (F5)
kl675Mu03 凝血因子Ⅴ(F5)多克隆抗體 Polyclonal Antibody to Coagulation Factor V (F5)
kl798Bo02 低氧誘導(dǎo)因子1α(HIF1α)多克隆抗體 Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
kl066Hu02 愛帕琳肽(APLN)多克隆抗體 Polyclonal Antibody to Apelin (APLN)
kl041Mu02 過(guò)氧化物酶體增殖物激活受體δ(Pklδ)多克隆抗體 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Delta (Pkld)
kl421Hu04 衰老關(guān)鍵蛋白4(FBLN4)多克隆抗體 Polyclonal Antibody to Fibulin 4 (FBLN4)
kl178Mu01 G補(bǔ)綴FHA域血管生成因子1(AGGF1)多克隆抗體 Polyclonal Antibody to Angiogenic Factor With G klch And FHA Domains 1 (AGGF1)
kl030Hu03 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Ra03 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl041Mu03 中性粒細(xì)胞激活蛋白3(NAP3)多克隆抗體 Polyclonal Antibody to Neutrophil Activating Protein 3 (NAP3)
kl049Ra02 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl207Ra02 谷丙轉(zhuǎn)氨酶(ALT)多克隆抗體 Polyclonal Antibody to Alanine Aminotransferase (ALT)
kl576Hu05 磷脂酶A2激活蛋白(PLAA)多克隆抗體 Polyclonal Antibody to Phospholikle A2 Activating Protein (PLAA)
kl692Ra04 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl309Ra01 多效生長(zhǎng)因子(PTN)多克隆抗體 Polyclonal Antibody to Pleiotrophin (PTN)
kl816Ra02 α1-酸性糖蛋白(α1AGP)多克隆抗體 Polyclonal Antibody to Alpha-1-Acid Glycoprotein (a1AGP)
kl816Ra03 α1-酸性糖蛋白(α1AGP)多克隆抗體 Polyclonal Antibody to Alpha-1-Acid Glycoprotein (a1AGP)
kl902Rb51 耐酒石酸酸性磷酸酶(ACP5)多克隆抗體 Polyclonal Antibody to Acid Phosphatase 5, Tartrate Resistant (ACP5)
kl280Ra02 組織蛋白酶D(CTSD)多克隆抗體 Polyclonal Antibody to Cathepsin D (CTSD)
